VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion
DOI: 10.1007/s12015-018-9821-1
Authors: Rachid Lahlil; Maurice Scrofani; Romain Barbet; Céline Tancredi; Anne Aries; Philippe Hénon
Step 1: mesoderm 1
day 0 ~ 2
culture “adherent” unknown species cell and human VSEL in “unspecified medium” for “2” days. For ECM, use “fibronectin/gelatin” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| valproic acid | 0.0025 | mol/l |
| 5-azacytidine | 5.0e-7 | mol/l |
| Ascorbic Acid | 1.0e-8 | mol/l |
| TGF-beta | 1.0e-6 | g/l |
Ideally, “mesoderm” should express “PDGFRa”, “KDR”, “MCAM”, “CD105”, “CD34”, “PTPRC” at the end of culture.